Заранее благодарю!
1. Acta Trop. 2013, 128, 494-503.
Tripathy S., Mahapatra S. K., Chattopadhyay S., Das S., Dash S. K., Majumder S., Pramanik P., Roy S.
A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection.
- DOI:
http://dx.doi.org/10.1016/j.actatropica.2013.07.011
Aditya N. P., Vathsala P. G., Vieira V., Murthy R. S. R., Souto E. B.
Advances in nanomedicines for malaria treatment.
- DOI:
http://dx.doi.org/10.1016/j.cis.2013.10.014
Rathi B., Singh A. K., Kishan R., Singh N., Latha N., Srinivasan S., Pandey K. C., Tiwari H. K., Singh B. K.
Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum.
- DOI:
http://dx.doi.org/10.1016/j.bmc.2013.05.052
Bell I. R., Schwartz G. E., Boyer N. N., Koithan M., Brooks A. J.
Advances in integrative nanomedicine for improving infectious disease treatment in public health.
Код: Выделить всё
www.sciencedirect.com/science/article/pii/S1876382012011146- DOI:
http://dx.doi.org/10.1016/j.eujim.2012.11.002
Kupetz E., Preu L., Kunick C., Bunjes H.
Parenteral formulation of an antileishmanial drug candidate – Tackling poor solubility, chemical instability, and polymorphism.
- DOI:
http://dx.doi.org/10.1016/j.ejpb.2013.02.001